Indian drug regulator tightens leash; terms 200 cos 'high risk'

Moneycontrol BureauThe Indian drug regulator Central Drugs Standard Control Organisation has brought more than 200 pharma companies under the classification of 'high-risk', cracking down on companies that violate essential norms akin to its American counterpart US Food and Drug Administration (USFDA), reports Business Standard.In the past few weeks, CDSCO has inspected around 135 manufacturing plants and laboratories all over the country with help from state regulators. The regulator's main focus is to assess the risk and quality standards of manufacturing units.CDSCO has till now kept out of sight. A lack of inspection officers and proper infrastructure has been the biggest reason it has not been able to keep on a tight leash on the India pharma space.